pharmacie et médicaments – Effets indésirables de la nouvelle formule du Levothyrox

This written question asks the French government about the adverse effects reported following the reformulation of the drug Levothyrox. It seeks information on the measures taken to address patient concerns and ensure drug safety. The question affects patients using Levothyrox, healthcare professionals, and pharmaceutical companies. It aims to clarify the regulatory oversight and patient protection measures in place for medication changes.